Antiemetics Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis

MARKET OVERVIEW

Antiemetics are the class of therapeutic agents that are effective against nausea and vomiting and related symptoms. Nausea and vomiting are the symptoms of several medical conditions such as, dizziness, motion sickness , emotional stress pregnancy and food poisoning. These drugs are frequently utilized to treat the side effects of other medications such as, chemotherapy, opioid analgesics and anaesthetic. The key market drivers for antiemetic market are, growing number of surgeries along with rising number of patients suffering from cancer and chronic disorders.

MARKET SCOPE

The "Global Antiemetics Market Analysis to 2031" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the antiemetics market with detailed market segmentation by drug class and application. The report provides key statistics on the market status of the leading antiemetics market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

•   Based on drug class the market is segmented as, 5-HT3 Receptor Antagonists, NK1 Receptor Antagonist, Dopamine Antagonists, Antihistamines, Cannabinoids, Benzodiazepines, Corticosteroids and Anticholinergic.
  
•   Based on application the market is segmented as, Chemotherapy-Induced Nausea and Vomiting, Gastroenteritis, Nausea and Vomiting of Pregnancy (NVP) and Post-Operative Nausea and Vomiting.
  

MARKET DYNAMICS

Drivers:

•   Growing number of surgeries along with rising number of patients suffering from cancer and chronic disorders.
  
•   Rising pool of patients with gastroenteritis issues and other gastric issues.
  
•   Increasing geriatric population across the globe and rising side effects with medication therapies.
  

Restraints:

•   However, the lack of a suitable animal model that can mimic human responses to antiemetic therapy is expected to restrain market growth during the forecast period.
  

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The antiemetics market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the antiemetics market in these regions.

IMPACT OF COVID-19 ON ANTIEMETICS MARKET
COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. There is slight slump in demand for antiemetic preparations because of lockdowns and restrictions. The demand also declined because of less of demand of antiemetic drugs from hospitals due to slow down of cancer and other diseases treatment therapies owing to COVID-19. According to the current market situation, the report further assesses the present and future effects of the COVID-19 pandemic on the overall market, giving more reliable and authentic projections In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.

MARKET PLAYERS

The report covers key developments in the antiemetics market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from antiemetics market are anticipated to lucrative growth opportunities in the future with the rising demand for antiemetics in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the antiemetics market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

•   Abbott
  
•   Dr. Reddy's Laboratories Ltd.
  
•   Aphios Corporation
  
•   Aurobindo Pharma
  
•   Merck Sharp and Dohme Corp
  
•   Eisai Co., Ltd
  
•   Glaxosmithkline Plc
  
•   Helsinn Healthcare SA
  
•   Heron Therapeutics, Inc
  
•   Sun Pharmaceutical Industries Ltd
  

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

Antiemetics Report Scope